Henderson_2016_Acta.Neuropathol_131_621

Reference

Title : Neuronal ceroid lipofuscinosis with DNAJC5\/CSPalpha mutation has PPT1 pathology and exhibit aberrant protein palmitoylation - Henderson_2016_Acta.Neuropathol_131_621
Author(s) : Henderson MX , Wirak GS , Zhang YQ , Dai F , Ginsberg SD , Dolzhanskaya N , Staropoli JF , Nijssen PC , Lam TT , Roth AF , Davis NG , Dawson G , Velinov M , Chandra SS
Ref : Acta Neuropathologica , 131 :621 , 2016
Abstract :

Neuronal ceroid lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (CLN1-14). Recently, mutations in the DNAJC5/CLN4 gene, which encodes the presynaptic co-chaperone CSPalpha were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPalpha and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (PPT1/CLN1) are biochemically linked. We find that in DNAJC5/CLN4 patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSPalpha is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and DNAJC5/CLN4 patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.

PubMedSearch : Henderson_2016_Acta.Neuropathol_131_621
PubMedID: 26659577
Gene_locus related to this paper: human-PPT1

Related information

Gene_locus human-PPT1

Citations formats

Henderson MX, Wirak GS, Zhang YQ, Dai F, Ginsberg SD, Dolzhanskaya N, Staropoli JF, Nijssen PC, Lam TT, Roth AF, Davis NG, Dawson G, Velinov M, Chandra SS (2016)
Neuronal ceroid lipofuscinosis with DNAJC5\/CSPalpha mutation has PPT1 pathology and exhibit aberrant protein palmitoylation
Acta Neuropathologica 131 :621

Henderson MX, Wirak GS, Zhang YQ, Dai F, Ginsberg SD, Dolzhanskaya N, Staropoli JF, Nijssen PC, Lam TT, Roth AF, Davis NG, Dawson G, Velinov M, Chandra SS (2016)
Acta Neuropathologica 131 :621